Acceptance, benefits and effectiveness of the CoronaWarn-App (COVID-19 warning app)
Organizational Data
- DRKS-ID:
- DRKS00023685
- Recruitment Status:
- Recruiting planned
- Date of registration in DRKS:
- 2020-12-18
- Last update in DRKS:
- 2020-12-18
- Registration type:
- Prospective
Acronym/abbreviation of the study
Corona-Warn-App
URL of the study
No Entry
Brief summary in lay language
The aim of the study is to scientifically investigate the acceptance, the benefit and the effectiveness of the Corona-Warn-App. For this purpose, patients who have tested positive for SARS-coV-2 and are being treated in an outpatient or inpatient setting by a study center are asked to fill out a questionnaire. This questionnaire includes specific questions about whether the patients have and use the app and general data such as age and gender.
Brief summary in scientific language
The study will examine the benefits, effectiveness and acceptance of the German Corona-Warn-App. Within the study, patients who tested positive for SARS-cov-2 and are treated in a study center as outpatients or inpatients will receive a questionnaire. The questionnaire contains questions about the app such as: Do the patients have the app? Do the patients use the app? How do the patients use the app? The questionnaire also includes general questions about the patient such as: age Gender Educational background Use of smartphones.
Health condition or problem studied
- ICD10:
- U07 - Emergency use of U07
- ICD10:
- U99.0
- Free text:
- COVID-19
- Healthy volunteers:
- No Entry
Interventions, Observational Groups
- Arm 1:
- Patients with evidence of infection with SARS-coV-2 to fill out a one-time questionnaire for the use of the corona warning app (COVID-19-Warn app).
Endpoints
- Primary outcome:
- Primary endpoint is the benefit of the corona warning app regarding whether SARS-coV-2 positive patients use the app and were warned by it.
- Secondary outcome:
- Correlation of app usage with general patient data.
Study Design
- Purpose:
- Prevention
- Retrospective/prospective:
- No Entry
- Study type:
- Non-interventional
- Longitudinal/cross-sectional:
- No Entry
- Study type non-interventional:
- No Entry
Recruitment
- Recruitment Status:
- Recruiting planned
- Reason if recruiting stopped or withdrawn:
- No Entry
Recruitment Locations
- Recruitment countries:
-
- Germany
- Number of study centers:
- Multicenter study
- Recruitment location(s):
-
- University medical center Medizinische Klinik 1 Erlangen
- Medical center Thüringen-Kliniken Georgius Agricola Saalfeld
- Medical center Krankenhaus Martha-Maria Nürnberg Nürnberg
- Medical center Kreiskrankenhaus St. Anna Höchstadt Höchstast
- Medical center Klinikum Fürth Fürth
Recruitment period and number of participants
- Planned study start date:
- 2020-12-18
- Actual study start date:
- No Entry
- Planned study completion date:
- No Entry
- Actual Study Completion Date:
- No Entry
- Target Sample Size:
- 500
- Final Sample Size:
- No Entry
Inclusion Criteria
- Sex:
- All
- Minimum Age:
- 18 Years
- Maximum Age:
- no maximum age
- Additional Inclusion Criteria:
- Infection with SARS-coV-2
Exclusion Criteria
lack of ability to consent
Addresses
Primary Sponsor
- Address:
- Medizinische Klinik 1 des Universitätsklinikums ErlangenUlmenweg 1891054 ErlangenGermany
- Telephone:
- 091318535000
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.medizin1.uk-erlangen.de/
- Investigator Sponsored/Initiated Trial (IST/IIT):
- Yes
Contact for Scientific Queries
- Address:
- Medizinische Klinik 1 des UK ErlangenDr. med. André JefremowUlmenweg 891054 ErlangenGermany
- Telephone:
- 091318535000
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.medizin1.uk-erlangen.de/
Contact for Public Queries
- Address:
- Medizinische Klinik 1 des UK ErlangenDr. med. André JefremowUlmenweg 1891054 ErlangenGermany
- Telephone:
- 091318535000
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.medizin1.uk-erlangen.de/
Sources of Monetary or Material Support
Institutional budget, no external funding (budget of sponsor/PI)
- Address:
- Medizinische Klinik 1 des Universitätsklinikums ErlangenUlmenweg 1891054 ErlangenGermany
- Telephone:
- 091318535000
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.medizin1.uk-erlangen.de/
Ethics Committee
Address Ethics Committee
- Address:
- Ethik-Kommission der Medizinischen Fakultät der Universität Erlangen-NürnbergKrankenhausstr. 1291054 ErlangenGermany
- Telephone:
- +40-9131-8522270
- Fax:
- +49-9131-8526021
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Vote of leading Ethics Committee
- Vote of leading Ethics Committee
- Date of ethics committee application:
- 2020-11-19
- Ethics committee number:
- 467_20B
- Vote of the Ethics Committee:
- Approved
- Date of the vote:
- 2020-12-16
Further identification numbers
- Other primary registry ID:
- No Entry
- EudraCT Number:
- No Entry
IPD - Individual Participant Data
- Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
- No
- IPD Sharing Plan:
- No.
Study protocol and other study documents
- Study protocols:
- No Entry
- Study abstract:
- No Entry
- Other study documents:
- No Entry
- Background literature:
- No Entry
- Related DRKS studies:
- No Entry
Publication of study results
- Planned publication:
- No Entry
- Publikationen/Studienergebnisse:
- No Entry
- Date of first publication of study results:
- No Entry
- DRKS entry published for the first time with results:
- No Entry
Basic reporting
- Basic Reporting / Results tables:
- No Entry
- Brief summary of results:
- No Entry